Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
10/2002
10/03/2002WO2002068687A8 Function and application of tob gene in central nervous system of mammal
10/03/2002WO2002062297A3 Methods and compositions for modulating gluconeogenesis using pgc-1
10/03/2002WO2002059153A3 Anticoagulants and their uses
10/03/2002WO2002055533A3 Methods of using imxp-888 and imxp-888 antagonists
10/03/2002WO2002034933A3 Methods and compositions for modifying biologically active target molecules
10/03/2002WO2002029086A3 Nucleic acid sequences differentially expressed in cancer tissue
10/03/2002WO2002029068A3 Virus-based amplification vector for plants
10/03/2002WO2002026944A3 METHODS AND COMPOSITIONS EMPLOYING A NOVEL STEAROYL-CoA DESATURASE-hSCD5
10/03/2002WO2002026193A3 Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas
10/03/2002WO2002024907A3 G-protein coupled receptor hfrbn63
10/03/2002WO2002024896A9 Screening assays for agonists or antagonists of receptor activat or of nf-kb
10/03/2002WO2002018407A3 Antisense oligonucleotides against vanilloid receptor 1
10/03/2002WO2002015949A3 Device for identifying the presence of a nucleotide sequence in a dna sample
10/03/2002WO2002000902A3 Regulation of anthocyanin pigment production
10/03/2002WO2001098355A3 Cgi-69 compositions and methods of use
10/03/2002WO2001096608A8 Detection of nucleic acids by type-specific hybrid capture method
10/03/2002WO2001096388A3 Compositions and methods for the therapy and diagnosis of colon cancer
10/03/2002WO2001094627A3 Assay techniques based on growth stage dependent expression in c. elegans
10/03/2002WO2001092561A3 Method of screening for negative cross resistance
10/03/2002WO2001088183A3 Method for the isolation of helicobacter pylori
10/03/2002WO2001084903A3 Method for detecting and identifying the presence of biological substances derived from birds, and oligonucleotides therefor
10/03/2002WO2001079465A3 Nucleic acids encoding polypeptides having haloperoxidase activity
10/03/2002WO2001077124A3 Haplotypes of the apoa4 gene
10/03/2002WO2001071004A3 Proteases
10/03/2002WO2001070976A3 Compositions and methods for the therapy and diagnosis of ovarian and endometrial cancer
10/03/2002WO2001062977A3 Methods and composition for diagnosing and treating pseudoxanthoma elasticum and related conditions
10/03/2002WO2001062064A3 Method for detecting cytosine methylation in dna samples
10/03/2002WO2001027857A3 Methods for generating databases and databases for identifying polymorphic genetic markers
10/03/2002WO2001023612A9 Determining mutations by selective reaction of the 2'-ribose position in hybridized oligonucleotides
10/03/2002WO2001021812A9 Phosphatases which activate map kinase pathways
10/03/2002WO2001021310A9 Device for rapid dna sample processing with integrated liquid handling, thermocycling, and purification
10/03/2002WO2001020015A9 Reverse transfection method
10/03/2002WO2001017343A9 Methods for evaluating a compound for its effect on skin
10/03/2002WO2000079285A9 Devices and methods for the performance of miniaturized homogeneous assays
10/03/2002WO2000073502A3 Essential genes and gene products for identifying, developing and optimising immunological and pharmacological active ingredients for the treatment of microbial infections
10/03/2002WO1999064459A3 Gene encoding organic anion transporter
10/03/2002US20020144310 Isolated polynucleotides and polypeptides relating to loci underlying resistance to soybean cyst nematode and soybean sudden death syndrome and methods employing same
10/03/2002US20020144298 Novel human genes and gene expression products
10/03/2002US20020143475 Management method of probe carrier, probe carrier manufacturing apparatus and probe carrier managing apparatus
10/03/2002US20020143471 Method of predicting and generating dna sequences and apparatus for carrying out the method
10/03/2002US20020143167 Methods for determining nucleotide sequences of single nucleic acid molecules
10/03/2002US20020143162 Methods
10/03/2002US20020143161 Members of the d52 gene family
10/03/2002US20020143155 Nucleotide sequences coding polypeptide for use in the treatment of inflammatory defects
10/03/2002US20020143111 High density, miniaturized arrays and methods of manufacturing same
10/03/2002US20020143110 High density, miniaturized arrays and methods of manufacturing same
10/03/2002US20020142988 G-coupled receptor showing selective affinity for ATP
10/03/2002US20020142986 Used in the diagnosis or prognosis of liver associated disorders
10/03/2002US20020142981 Gene expression profiles in liver cancer
10/03/2002US20020142977 Administering an immunostimulatory nucleic acid molecule in an amount effective to increase antigen-specific cytotoxic T lymphocyte (CTL) activity in a CD4+ T cell-deficient individual
10/03/2002US20020142975 Antisense inhibitor of recql4 expression
10/03/2002US20020142961 As pharmaceuticals, diagnostics, biosensors and bioreactors
10/03/2002US20020142939 HMGI proteins in cancer and obesity
10/03/2002US20020142468 Interfering with fungal gene expression; obtain fungal sample, incubate with modulator, monitor transcription and propagation of fungal structures
10/03/2002US20020142451 Generation of nodulation inoculant; obtain nutrient broth, mix with iron, monitor cell density factor, evaluate nodulation in propagating plants
10/03/2002US20020142449 Compositions and methods useful for HCV infection
10/03/2002US20020142448 Antibody for use in the diagnosis, treatment and prevention of bone disorders and cancer
10/03/2002US20020142447 DNA encoding the human serine protease EOS
10/03/2002US20020142446 DNA encoding the human serine protease EOS
10/03/2002US20020142444 AL-2 neurotrophic factor
10/03/2002US20020142440 Peptide for use in the diagnosis and treatment of inflammation, cancer, arteriosclerosis and degenerative disorders
10/03/2002US20020142432 Human endosulfine gene
10/03/2002US20020142430 Peptide for use in the treatment of inflammation, cancer, arteriosclerosis and psoriasis
10/03/2002US20020142429 Elongation factor-2 kinase (EF-2 kinase) and methods of use therefor
10/03/2002US20020142428 Novel kinases and uses thereof
10/03/2002US20020142426 33945, a human glycosyltransferase family member and uses therefor
10/03/2002US20020142424 Protein for use as a bioluminescent signaling tool
10/03/2002US20020142421 Isolated human aminoacylase, nucleic acid molecules encoding human aminoacylase, and uses thereof
10/03/2002US20020142420 Cloned leptospira outer membrane protein
10/03/2002US20020142411 Enzymatic deposition and alteration of metals
10/03/2002US20020142402 Method for synthesis of nucleic acids
10/03/2002US20020142398 Chemokine expressed in fetal spleen, its production and uses
10/03/2002US20020142397 Genetically engineering cell; obtain cell, incubate with cell growth factor, remove nucleus or chromatin, insert into cell, propagate cell
10/03/2002US20020142394 Exonuclease-mediated gene assembly in directed evolution
10/03/2002US20020142392 Human melanocyte stimulating hormone receptor polypeptide and DNA
10/03/2002US20020142378 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/03/2002US20020142375 Nucleotide sequences coding G protein coupled receptors for use in the diagnosis and treatment of cancer, adult respiratory distress, nervous system disorders and arthritis
10/03/2002US20020142371 Detecting target polynucleotides in a test sample; obtain sample, incubate with probe, detect signal, presence of signal indicates target sequences
10/03/2002US20020142366 Method for isolation and identification of Escherichia coli 0157:H7 and plating media for said process
10/03/2002US20020142365 Testing kit and methodology for testing for the presence of microorganisms
10/03/2002US20020142364 Evaluating microbiocidal activity of perfuming agent; obtain sample, solubilize tests compound, incubate with bacteria, reduce bacterial concentration, spread, monitor propagation of bacteria, compare to control
10/03/2002US20020142362 Kit for use in the detection of and treatment of vision defects; wound healing agents
10/03/2002US20020142357 TNF receptor action modulation
10/03/2002US20020142353 Connective tissue growth factor (CTGF) and methods of use
10/03/2002US20020142351 Peptide or protein microassay method and apparatus
10/03/2002US20020142350 Viral nucleotide sequences for use in the prevention and treatment of viral diseases
10/03/2002US20020142344 Targeted molecular bar codes and methods for using the same
10/03/2002US20020142343 Preparing substrate for detecting preferential particle in sample; obtain sample, expose to elution buffer, detect preferential particle by desorption spectrometry, incubate with substrate, recover preferential particle
10/03/2002US20020142342 Nucleic acid analysis using non-templated nucleotide addition
10/03/2002US20020142341 Method and apparatus for producing probe carrier
10/03/2002US20020142336 Detecting preferential nucleotide in nucleic acid sequence; obtain nucleotide sequence sample, incubate with primer, denature, hybridize, detection of signal indicates presence of preferential nucleic acids and sequences
10/03/2002US20020142334 Detecting preferential enzymatic activity; generate solid support, incubate with nicotinamide adenine dinucleotide, expose to enzyme, detect and marker complexes and quantify enzyme activity
10/03/2002US20020142333 Heat resistant enzymatic polypeptide for use as a tool in nucleotide sequences analysis
10/03/2002US20020142332 Monitoring concentration of preferential nucleotide sequences; obtain sample containing nucleotide sequences, incubate with modulator, release nucleotides generated in fluid, measure radioactiviy in sample
10/03/2002US20020142330 Novel glutamate receptor modulatory proteins and nucleic acid molecules and uses therefor
10/03/2002US20020142328 Method of determining a chemotherapeutic regimen by assaying gene expression in primary tumors
10/03/2002US20020142327 Expression analysis of smarc nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
10/03/2002US20020142326 Screening sample for preferential microorganisms; obtain sample, inubate with probes, detect hybridization, classify microorganisms
10/03/2002US20020142325 PAK 2: modulators of lymphocyte activation
10/03/2002US20020142324 Preparing clonal library of genetically engineered nucleotide sequences; obtain nucleotide sequences, incubate with vector and enzyme, seal nucleotide sequences into vector, transform cells, recover clonal library